Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening.

CT measures of CVD and COPD provides small but reproducible improvements to nodule-based lung cancer risk prediction accuracy from 3 years onwards. Self-reported patient characteristics may not be of added predictive value when CT information is available.